Metabotropic glutamate receptor subtype 5 antagonism in learning and memory

被引:48
作者
Simonyi, Agnes [1 ]
Schachtman, Todd R.
Christoffersen, Gert R. J. [2 ]
机构
[1] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA
[2] Univ Copenhagen, Dept Biol, DK-1168 Copenhagen, Denmark
关键词
Metabotropic glutamate receptor 5; Spatial learning; Fear conditioning; Avoidance learning; MPEP; MTEP; Locomotion; (Rat); (Mouse); CONDITIONED TASTE-AVERSION; LONG-TERM POTENTIATION; MGLU5; RECEPTOR; GROUP-I; ANXIOLYTIC-LIKE; 2-METHYL-6-(PHENYLETHYNYL)-PYRIDINE MPEP; LOCOMOTOR-ACTIVITY; SPLICE VARIANTS; PHARMACOLOGICAL CHARACTERIZATION; GLUTAMATE-RECEPTOR-5; ANTAGONIST;
D O I
10.1016/j.ejphar.2009.12.039
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
The role of the metabotropic glutamate receptor 5 (mGlu(5) receptor) in learning and memory and other behaviors are reviewed by examining the influence of selective antagonists and genetic knockout on performance. This receptor is involved in spatial learning, contextual fear conditioning, inhibitory avoidance, fear potentiated startle, and conditioned taste aversion. However, mGlu(5) receptor antagonists have proven to be ineffective in other learning tasks, such as the delayed-match-to-position test and a three-hole spatial learning task. Locomotion is often decreased by mGlu(5) receptor antagonists; and other behaviors such as social interaction and consummatory responses can also be affected. In mGlu(5) receptor knockout mice, performance in contextual fear conditioning and spatial water maze tasks is impaired. Although the available evidence is suggestive of an important contribution of mGlu(5) receptors to cognitive functions, further studies are needed, particularly those with in vivo evaluation of the role of mGlu(5) receptors in selective brain regions in different stages of memory formation. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:17 / 25
页数:9
相关论文
共 96 条
[1]
ABE T, 1992, J BIOL CHEM, V267, P13361
[2]
In vivo receptor occupancy of mGlu5 receptor antagonists using the novel radioligand [3H]3-methoxy-5-(pyridin-2-ylethynyl)pyridine) [J].
Anderson, JJ ;
Bradbury, MJ ;
Giracello, DR ;
Chapman, DF ;
Holtz, G ;
Roppe, J ;
King, C ;
Cosford, NDP ;
Varney, MA .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 473 (01) :35-40
[3]
The effect of the mGlu5 receptor antagonist MPEP in rodent tests of anxiety and cognition: a comparison [J].
Ballard, TM ;
Woolley, ML ;
Prinssen, E ;
Huwyler, J ;
Porter, R ;
Spooren, W .
PSYCHOPHARMACOLOGY, 2005, 179 (01) :218-229
[4]
Allosteric enhancement of metabotropic glutamate receptor 5 function promotes spatial memory [J].
Balschun, D. ;
Zuschratter, W. ;
Wetzel, W. .
NEUROSCIENCE, 2006, 142 (03) :691-702
[5]
Inhibition of mGluR5 blocks hippocampal UP in vivo and spatial leaming in rats [J].
Balschun, D ;
Wetzel, W .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2002, 73 (02) :375-380
[6]
A temporally distinct role for group I and group II metabotropic glutamate receptors in object recognition memory [J].
Barker, GRI ;
Bashir, ZI ;
Brown, MW ;
Warburton, EC .
LEARNING & MEMORY, 2006, 13 (02) :178-186
[7]
Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests [J].
Belozertseva, I. V. ;
Kos, T. ;
Popik, P. ;
Danysz, W. ;
Bespalov, A. Y. .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 (03) :172-179
[8]
Expression and signaling of group I metabotropic glutamate receptors in astrocytes and microglia [J].
Biber, K ;
Laurie, DJ ;
Berthele, A ;
Sommer, B ;
Tölle, TR ;
Gebicke-Härter, PJ ;
van Calker, D ;
Boddeke, HWGM .
JOURNAL OF NEUROCHEMISTRY, 1999, 72 (04) :1671-1680
[9]
Effects of metabotropic glutamate receptor 5 on latent inhibition in conditioned taste aversion [J].
Bills, C ;
Schachtman, TR ;
Serfozo, P ;
Spooren, WPJM ;
Gasparini, F ;
Simonyi, A .
BEHAVIOURAL BRAIN RESEARCH, 2005, 157 (01) :71-78
[10]
Metabotropic glutamate receptor mGlu5 is a mediator of appetite and energy balance in rats and mice [J].
Bradbury, MJ ;
Campbell, U ;
Giracello, D ;
Chapman, D ;
King, C ;
Tehrani, L ;
Cosford, NDP ;
Anderson, J ;
Varney, MA ;
Strack, AM .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 313 (01) :395-402